Successful pregnancy after total body irradiation and bone marrow transplantation for acute leukaemia.
We report successful pregnancies in two young women (aged 24 and 20 years) following allogeneic bone marrow transplantation (BMT) for acute non-lymphoblastic leukaemia. Conditioning therapy consisted of cyclophosphamide (120 mg/kg) and total body irradiation (TBI, 12 Gy) in 2 Gy fractions once daily for 6 days or twice daily for 3 days. Graft-versus-host disease prophylaxis was with methotrexate alone. Both women were amenorrhoeic after BMT and gonadal testing indicated hypergonadotrophic hypogonadism. Both women had normal pregnancies (2 years and 5 years after BMT) resulting in normal healthy infants. Previously successful pregnancy has been reported after TBI in three women in whom the TBI dose was less than 8 Gy. Our cases illustrate that normal outcome of pregnancy is possible at even higher doses of TBI.
Giri
N
N
Department of Paediatric Haematology/Oncology, Prince of Wales Hospital, Randwick, NSW Australia.
Vowels
M R
MR
Barr
A L
AL
Mameghan
H
H
D000328:Adult; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000532:radiotherapy / Q000601:surgery; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D010053:Ovary / Q000503:physiopathology / Q000528:radiation effects; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic; D011256:Pregnancy Outcome; D011879:Radiotherapy Dosage; D014916:Whole-Body Irradiation
D003520:Cyclophosphamide; D008727:Methotrexate